期刊文献+

白细胞介素9在肾癌组织中的表达及其临床意义 被引量:1

Expression of interleukin-9 in renal tumor tissues and its clinical significance
下载PDF
导出
摘要 目的探讨白细胞介素9(IL-9)在肾癌组织中的表达阳性率及临床意义。方法收集苏州大学附属第一医院66例行肾癌手术患者的组织标本,采用免疫组化法检测肾透明细胞癌组织和癌旁组织中IL-9的阳性表达情况并比较其差异,同时分析癌组织中IL-9的表达与患者临床病理特征之间的关系。结果在癌旁组织中,IL-9蛋白阳性表达61例、阴性表达5例;在肾透明细胞癌组织中,IL-9蛋白阳性表达7例、阴性表达59例,两者差异有统计学意义(P<0.01)。肾透明细胞癌组织中IL-9蛋白的表达水平与患者的R.E.N.A.L.评分(P=0.028)及分化程度(P=0.004)呈负相关,而与性别(P=0.072)、年龄(P=0.257)、体重质量指数(P=0.794)、肿瘤直径(P=0.419)及TNM分期(P=0.540)无关。结论肾癌组织中IL-9表达阳性率低于癌旁组织,且在肾癌组织中,R.E.N.A.L.评分越高或分化程度越差,则IL-9阳性表达越低,提示IL-9在肾癌组织微环境中可能具有一定的保护作用。 Objective To explore the positive expression level of IL-9 in renal tumor tissues and its clinical significance.Methods Renal tumor tissues as well as paired adjacent normal tissues were collected and then IL-9 expression level was detected by immunohistochemistry.Also,the correlation between IL-9 expression and the clinicopathological features was analyzed.Results The expression of IL-9 in renal tumor tissues was significantly lower than that in adjacent normal tissues(P<0.01).The correlation between IL-9 expression level and R.E.N.A.L.scores(P=0.028)as well as differentiation(P=0.004)was found negative.There was no significant difference in clinicopathological features including gender(P=0.072),age(P=0.257),BMI(P=0.794),tumor size(P=0.419)or TNM staging(P=0.540).Conclusions It was found that IL-9 positive expression in renal tumor tissues was lower than that in adjacent normal tissues.Low positive expression of IL-9 was detected when R.E.N.A.L.score was high or the cell differentiation was poor,suggesting that IL-9 may positively participate in the tumor microenvironment of renal tumor.
作者 曹志骏 张志昱 欧阳骏 浦金贤 侯建全 张江磊 CAO Zhijun;ZHANG Zhiyu;OUYANG Jun;PU Jinxian;HOU Jianquan;ZHANG Jianglei(Department of Urology, Suzhou Ninth People's Hospital, Suzhou 215000, China)
出处 《现代泌尿生殖肿瘤杂志》 2020年第2期101-103,109,共4页 Journal of Contemporary Urologic and Reproductive Oncology
基金 苏州科技计划项目(SYS2019053)。
关键词 肾癌 IL-9 免疫组织化学 Renal tumor Interleukin-9 Munohistochemistry
  • 相关文献

参考文献6

二级参考文献33

  • 1Kaplan MH. Th9 cells:differentiation and disease [ J ]. Immunol Rev, 2013,252( 1 ) : 104-115.
  • 2Lu Y, Hong S, Li H, et al. Th9 cells promote antitumor immune re- sponses in vivo[ J]. J Clia Invest,2012,122( 11 ) :4160-4171.
  • 3Kuang DM,Peng C,Zhao Q, et al. Activated monocytes in peritumoral stroma of hepatocellular carcinoma promote expansion of memory T helper 17 cells[ J]. Hepatology,2010,51 ( 1 ) :154-164.
  • 4Veldhoen M, Uyttenhove C, Van Snick J, et al. Transforming growth factor-beta ' reprograms' the differentiation of T helper 2 ceils and promotes an interleukin 9-producing subset[ J]. Nat Immunol,2008,9 (12) : 1341-1346.
  • 5Dardalhon V, Awasthi A, Kwon H, et al. 1L-4 inhibits TGF-beta-in- dueed Foxp3 + T cells and, together with TGF-beta, generates IL-9 + IL-10 + Foxp3 ( - ) effector T cells[ J]. Nat Immuno1,2008,9 ( 12 ) : 1347-1355.
  • 6Catalano V,Turdo A,Di Franco S, et al. Tumor and its microenviron- merit : a synergistic interplay J ]. Semin Cancer Biol, 2013,23 ( 6 Pt B) :522-532.
  • 7Beasley MB, Brambilla E, Travis WD. The 2004 World Health Organization classification of lung tumors EJJ. Semin Roentgenol, 2005, 40 (2)= 90-97.
  • 8Travis WD, Travis LB, Devesa SS. Lung cancer E J3. Cancer, 1995, 75 (1Suppll): 191-202.
  • 9Worden FP, Kalemkerian GP. Therapeutic advances in small cell lung cancer rJ]. Expert Opin Investig Drugs, 2000, 9 (3): 565-579.
  • 10Socinski MA, Bogart JA. Limited-stage small-cell lung cancer: the current status of combined-modality therapy [J]. JClinOncol, 2007, 25 (26): 4137-4145.

共引文献29

同被引文献10

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部